SYNAPTICS Inc — Director's Dealing 2020

May 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2020-05-11

Reporting Person: McFarland John (SVP, General Counsel & Sec.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-11	Common Stock	M	3277	$45.32	Acquired	24535	Direct
2020-05-11	Common Stock	S	4251	$65.5911	Disposed	20284	Direct
2020-05-11	Common Stock	S	2343	$66.2929	Disposed	17941	Direct
2020-05-11	Common Stock	S	61	$67.14	Disposed	17880	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-11	Employee Stock Option (Right to Buy)	$45.32	M	3277	Disposed	2024-08-04	Common Stock (3277)	Direct

Footnotes

F1: Includes 65 shares acquired under the Issuer's employee stock purchase plan in November 2019 and 20 shares acquired under the Issuer's employee stock purchase plan in March 2020.

F2: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.99 to $65.94, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.99 to $66.86,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of August 4, 2017, with the remaining two-thirds vesting quarterly until fully vested on August 4, 2020.